Related Experiment Video

Updated: Feb 13, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K

Treatment of uveal melanoma: where are we now?

Jessica Yang1, Daniel K Manson1, Brian P Marr2

  • 1Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA.

Therapeutic Advances in Medical Oncology
|March 3, 2018
PubMed

Insights

Uveal melanoma, an eye cancer, often spreads despite treatment. New strategies are needed to improve outcomes for patients with metastatic uveal melanoma, focusing on targeted therapies and immunotherapies.

Area of Science:

  • Ophthalmology
  • Oncology
  • Medical Research

Background:

  • Uveal melanoma is the most common primary intraocular malignancy in adults.
  • Despite primary treatment, approximately 50% of patients develop metastatic disease.
  • Current therapies for metastatic uveal melanoma have limited efficacy, necessitating novel approaches.

Purpose of the Study:

  • To provide a comprehensive and updated overview of uveal melanoma.
  • To discuss disease biology, risk stratification, and management of primary disease.
  • To review current treatment strategies for adjuvant and metastatic settings, including targeted therapy and immunotherapy.

Main Methods:

  • This is a review article.
  • Literature search and synthesis of existing data on uveal melanoma.
  • Analysis of current and emerging treatment modalities.

Main Results:

  • Uveal melanoma presents unique biological and immunological characteristics.
  • Risk stratification aids in predicting metastatic potential.
  • Adjuvant and metastatic settings require tailored therapeutic strategies.

Conclusions:

  • Effective management and treatment approaches for uveal melanoma are crucial.
  • Optimizing targeted therapy and immunotherapy holds promise for improving patient outcomes.
  • Further research is needed to address the unmet needs in uveal melanoma treatment.
Keywords:
adjuvant therapyimmunotherapyliver-directed therapytargeted therapyuveal melanoma

More Related Videos

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice04:02

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice

Published on: November 6, 2019

9.3K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
981
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K